Case Study: GenomeLink achieves 77% CAC reduction with nine.am

How GenomeLink grew with 77% cac reduction over 3+ years

nine.am partnered with GenomeLink to address the challenge of scaling user acquisition for its DNA analysis platform. The company needed to grow in the competitive genetic testing market and educate consumers on getting more value from their existing genetic test results.

The solution from nine.am involved a multi-format creative production system, cross-platform optimization, and a conversion-focused testing framework. This approach achieved a 77% reduction in customer acquisition cost over three years, alongside the consistent production of 70 unique creative assets per month across six different formats.

GenomeLink